There has also been substantial interest in G-CSF for ALS, however early phase clinical trials have failed to show efficacy (Cashman et al., 2008; Nefussy et al., 2010; Chio et al., 2011; Duning et al., 2011). Here, CSF3 is linked to amyotrophic lateral sclerosis.